Paper35567447
Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers.
Akiyama T and 3 others. Clin Transl Med, 2022. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers. Papers, record 35567447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35567447
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyotrophic Lateral Sclerosis | Major topic |
| Frontotemporal Dementia | Major topic |
| Pick Disease of the Brain | Major topic |
| Biomarkers | |
| DNA-Binding Proteins | |
| Humans |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 NS097273 | NINDS NIH HHS | United States | R35NS097273 | PubMed and NIH | NIH RePORTER |
| P01 NS084974 | NINDS NIH HHS | United States | P01NS084974 | PubMed and NIH | NIH RePORTER |
| U54 NS123743 | NINDS NIH HHS | United States | U54NS123743 | PubMed and NIH | NIH RePORTER |
| T32 AG047126 | NIA NIH HHS | United States | T32AG047126 | PubMed and NIH | NIH RePORTER |
| R35 NS097263 | NINDS NIH HHS | United States | R35NS097263 | PubMed and NIH | NIH RePORTER |
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35197626 | TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. | Nature | 2022 | https://conductscience.org/library/papers/35197626 | PubMed |
| 2 | 35334233 | Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/35334233 | PubMed |
| 3 | 31332509 | Splicing repression is a major function of TDP-43 in motor neurons. | Acta Neuropathol | 2019 | https://conductscience.org/library/papers/31332509 | PubMed |
| 4 | 24931836 | C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. | Ann Neurol | 2014 | https://conductscience.org/library/papers/24931836 | PubMed |
| 5 | 31831332 | Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model. | Neuron | 2020 | https://conductscience.org/library/papers/31831332 | PubMed |
| 6 | 20400460 | TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. | Hum Mol Genet | 2010 | https://conductscience.org/library/papers/20400460 | PubMed |
| 7 | 34873335 | Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. | Nat Genet | 2021 | https://conductscience.org/library/papers/34873335 | PubMed |
| 8 | 33340024 | Improving clinical trial outcomes in amyotrophic lateral sclerosis. | Nat Rev Neurol | 2021 | https://conductscience.org/library/papers/33340024 | PubMed |
| 9 | 26829591 | A new view of transcriptome complexity and regulation through the lens of local splicing variations. | Elife | 2016 | https://conductscience.org/library/papers/26829591 | PubMed |
| 10 | 23393093 | The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. | Science | 2013 | https://conductscience.org/library/papers/23393093 | PubMed |
| 11 | 32690681 | Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32690681 | PubMed |
| 12 | 25239657 | Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. | Mol Neurodegener | 2014 | https://conductscience.org/library/papers/25239657 | PubMed |
| 13 | 32790644 | Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32790644 | PubMed |
| 14 | 21944779 | A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. | Neuron | 2011 | https://conductscience.org/library/papers/21944779 | PubMed |
| 15 | 35567447 | Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/35567447 | PubMed |
| 16 | 26162714 | UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort. | J Neurol | 2015 | https://conductscience.org/library/papers/26162714 | PubMed |
| 17 | 33839324 | Gene therapy for ALS: A review. | Mol Ther | 2021 | https://conductscience.org/library/papers/33839324 | PubMed |
| 18 | 31201598 | UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis. | Neurol Sci | 2019 | https://conductscience.org/library/papers/31201598 | PubMed |
| 19 | 33057172 | Spinal muscular atrophy - insights and challenges in the treatment era. | Nat Rev Neurol | 2020 | https://conductscience.org/library/papers/33057172 | PubMed |
| 20 | 25132468 | Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. | Neuron | 2014 | https://conductscience.org/library/papers/25132468 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983891 | TDP-43-related cryptic splicing reflects pathological heterogeneity in amyotrophic lateral sclerosis. | Acta Neuropathol Commun | 2026 | https://conductscience.org/library/papers/42983891 | PubMed |
| 42141120 | Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE). | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42141120 | PubMed |
| 41389796 | TDP-43 dysfunction compromises UPF1-dependent mRNA metabolism in ALS. | Neuron | 2026 | https://conductscience.org/library/papers/41389796 | PubMed |
| 41125872 | Pathogenic UNC13A variants cause a neurodevelopmental syndrome by impairing synaptic function. | Nat Genet | 2025 | https://conductscience.org/library/papers/41125872 | PubMed |
| 41120750 | TDP-43 nuclear loss in FTD/ALS causes widespread alternative polyadenylation changes. | Nat Neurosci | 2025 | https://conductscience.org/library/papers/41120750 | PubMed |
| 40825784 | Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial. | Nat Commun | 2025 | https://conductscience.org/library/papers/40825784 | PubMed |
| 40707625 | ALS-associated RNA-binding proteins promote UNC13A transcription through REST downregulation. | EMBO J | 2025 | https://conductscience.org/library/papers/40707625 | PubMed |
| 40661315 | Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/40661315 | PubMed |
| 40575326 | Endogenous SNAP-Tagging of Munc13‑1 for Monitoring Synapse Nanoarchitecture. | JACS Au | 2025 | https://conductscience.org/library/papers/40575326 | PubMed |
| 39511939 | Amyotrophic lateral sclerosis represents corticomotoneuronal system failure. | Muscle Nerve | 2025 | https://conductscience.org/library/papers/39511939 | PubMed |
| 39114608 | Abnormal Splicing Events due to Loss of Nuclear Function of TDP-43: Pathophysiology and Perspectives. | JMA J | 2024 | https://conductscience.org/library/papers/39114608 | PubMed |
| 38601850 | Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and amyotrophic lateral sclerosis. | Front Aging Neurosci | 2024 | https://conductscience.org/library/papers/38601850 | PubMed |
| 38443601 | RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS. | Acta Neuropathol | 2024 | https://conductscience.org/library/papers/38443601 | PubMed |
| 38328059 | TDP-43 nuclear loss in FTD/ALS causes widespread alternative polyadenylation changes. | bioRxiv | 2024 | https://conductscience.org/library/papers/38328059 | PubMed |
| 38079474 | The new missense G376V-TDP-43 variant induces late-onset distal myopathy but not amyotrophic lateral sclerosis. | Brain | 2024 | https://conductscience.org/library/papers/38079474 | PubMed |
| 37949994 | Biomarkers in amyotrophic lateral sclerosis: current status and future prospects. | Nat Rev Neurol | 2023 | https://conductscience.org/library/papers/37949994 | PubMed |
| 37466726 | Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum. | Acta Neuropathol | 2023 | https://conductscience.org/library/papers/37466726 | PubMed |
| 36827976 | Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology. | Stem Cell Reports | 2023 | https://conductscience.org/library/papers/36827976 | PubMed |
| 35768560 | Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease. | Sci Rep | 2022 | https://conductscience.org/library/papers/35768560 | PubMed |
| 35567447 | Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/35567447 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C9orf72 | 203228 | PubTator's text mining | https://conductscience.org/library/genes/203228 | NCBI Gene |
| CFC1 | 55997 | PubTator's text mining | https://conductscience.org/library/genes/55997 | NCBI Gene |
| FUS | 2521 | PubTator's text mining | https://conductscience.org/library/genes/2521 | NCBI Gene |
| NEFL | 4747 | PubTator's text mining | https://conductscience.org/library/genes/4747 | NCBI Gene |
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 | NCBI Gene |
| STMN2 | 11075 | PubTator's text mining | https://conductscience.org/library/genes/11075 | NCBI Gene |
| TARDBP | 23435 | PubTator's text mining | https://conductscience.org/library/genes/23435 | NCBI Gene |
| UNC13A | 23025 | PubTator's text mining | https://conductscience.org/library/genes/23025 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35567447
GET https://conductscience.org/api/papers/v1/35567447/references?page=2